Bio-Techne (NASDAQ: TECH) reported Q1 EPS of $0.42, $0.04 better than the analyst estimate of $0.38. Revenue for the quarter came in at $289.5 million versus the consensus estimate of $280.22 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.